Latest West Pharmaceutical Services (WST) Headlines
West to Present at Barclays Conference
Marketwire - Thu Mar 06, 7:02AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the 2014 Barclays Global Healthcare Conference Healthcare Conference in Miami, FL. Management will present an overview of West's business and outlook on Thursday, March 13, 2013 at 9:00 AM Eastern Time.
Concise Analysis of the International Bolus Injectors Market, 2014 - 2024
M2 - Tue Mar 04, 6:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/jpbd3g/bolus_injectors) has announced the addition of the "Concise Analysis of the International Bolus Injectors Market, 2014 - 2024" report to their offering. The injectable drug delivery market holds significant potential for the future. From conventional syringes with vials and painful needles to the modern-day pre-filled syringes, pen-injectors, needle free injectors and auto-injectors, the injectable drug delivery devices market has come a long way. Taking the concept of self-injectors to a new stratum, Bolus Injectors' have surfaced recently. Also known as non-insulin patch pumps, these devices not only offer a range of benefits to the end users but also provide a number of additional benefits to other stakeholders in the industry. One of the main drivers for the perceived growth of bolus injectors is the large number of biologics currently under development. A majority of these molecules are highly viscous and are required to be delivered in volumes of greater than 1 ml. The absence of devices which can safely administer these drugs is currently a big unmet need in the market. However, the early signs are encouraging. Despite the uncertainties related to the device development and approval, many companies are investing time, money and resources to develop novel devices. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Overview And Market Background 4. Target Drugs For Bolus Injectors 5. Product Profiles 6. Market Size And Forecast 7. Swot Analysis 8. Company Profiles 9. Interview Transcripts 10. Conclusion 11. Appendix 1: Tables 12. Appendix 2: List Of Companies Companies Mentioned: - AbbVie - Abbott - BMS - Boehringer Ingelheim - Calando Pharmaceuticals - Calibra Medical - Dekkun - Denderon - Eisai - Elcam Medical - Eli Lilly - Five Prime Therapeutics - Future Injection Technologies - Genentech - Genethon - Isis Pharmaceuticals - J&J - Janssen Biotech - Kyowa Hakko Kirin - Lincoln Medical Limited - MacroGenics - Nuron Biotech - Octapharma - OncoGenex Technologies - Pfizer - PhaseBio Pharmaceuticals - Roche - SteadyMed Therapeutics - Synageva BioPharma - TaiMed Biologics - Takeda Pharmaceuticals - VBL Therapeutics - West Pharmaceutical Services - Xbiotech - Ypsomed - ZZ Biotech For more information visit http://www.researchandmarkets.com/research/jp..._injectors
Insider Trading Alert - KMB, IBKR And WST Traded By Insiders
at The Street - Thu Feb 27, 9:30AM CST
Stocks with insider trader activity include KMB, IBKR and WST
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
West Pharm sales fall short
at Investor's Business Daily - Thu Feb 20, 6:14PM CST
The maker of packaging and delivery devices for drugs and related consumer products said Q4 EPS climbed 22.6% to 38 cents, in line with estimates. Revenue rose 7.8% to $346.6 mil, below projections for $348.7 mil. West Pharmaceutical (WST) forecast...
West Appoints Director and Announces Second Quarter 2014 Dividend
Marketwire - Thu Feb 20, 7:22AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors increased the size of the Board to eleven and appointed Myla Lai-Goldman, M.D., for a term that will expire at the 2014 Annual Meeting of Shareholders, when she will stand for election.
West Announces Fourth Quarter 2013 Results
Marketwire - Thu Feb 20, 6:01AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth quarter and full year 2013 and provided annual financial guidance for 2014.
Global Pharmaceutical Packaging Market Report 2014-2018: Plastic bottles, Blister packs, Caps & Closures, Ampoules, Vials and Others
M2 - Fri Feb 14, 9:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/zkfvpk/pharmaceutical) has announced the addition of the "Pharmaceutical Packaging Market by Packaging Type. Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018" report to their offering. The global pharmaceutical packaging market is expected to grow at a CAGR of 6.7% from 2013 to 2018 to reach a value of $78.79 billion. The pharmaceutical packaging report analyzes pharmaceutical packaging market by type of packaging and drug delivery technologies; globally & regionally. The report familiarizes the industry players with the market trends, opportunities, drivers, and challenges. This report identifies the factors driving or inhibiting the growth of each segment to support its analysis of market trends and forecasts. In addition to the market size, data trends, and forecasts; the report also highlights the key market opportunities for the stakeholders and draws a competitive landscape in which the key market developments of the top companies in the market are profiled. The packaging market by drug delivery type is growing at a CAGR of 9.1% and constitutes a significant part of the overall pharmaceutical packaging market. The market is expected to be pushed by off-patenting of drugs, expanding generics market, and rapidly growing drug delivery market. Due to increasing generic and contract manufacturing activities in Asia-Pacific, especially in India and China, the emerging geographies are expected to register maximum growth. Advances in biotechnology often lead to the introduction of new therapies that must be injected; the pharmaceutical packaging market is expected to witness fastest growth from pre-fillable syringes and parenteral vials. Availability of raw materials and price volatility coupled with changing health regulations are the major deterrents that are curbing the growth of this market. The fastest growth in the pharma packaging market is expected to come from pre-fillable syringes, labels and accessories, blister packs, temperature controlled medicines packaging, and few niche products, which will continue to expand in the coming years. Mergers and acquisitions in the recent past have indicated that the industry is on its way to consolidation globally and global packaging suppliers are strengthening their presence in emerging markets. All these factors, along with the growing pharma industry, will continue to drive the demand for packaging. However, the packaging industry will have to overcome challenges, such as the availability and price volatility of raw materials and changing health regulations, in order to meet the increasing demand from the growing pharma industry. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Premium Insight 5 Market Dynamics 6 Pharmaceutical Packaging Market, By Packaging Type 7 Pharmaceutical Packaging Market, By Packaging Material 8 Pharmaceutical Packaging Market, By Drug Delivery Type 9 Pharmaceutical Packaging Market, By Geography 10 Packaging Market For Veterinary Vaccines 11 Competitive Landscape 12 Company Profiles - Amcor Ltd. - Aptargroup, Inc. - Becton, Dickinson & Company - Capsugel Inc. - Catalent Pharma Solutions Inc. - Ccl Industries Inc. - Clondalkin Group Holdings B.V. - Datwyler Holding Inc. - Gerresheimer Ag - Global Closure Systems Ltd - Intrapac Group - Klockner Pentaplast Group - Meadwestvaco Corporation - Nypro Inc. - Rexam Plc - Rpc Group Plc - Schott Ag - Steripack Limited - Vitro, S.A.B. De C.V. - West Pharmaceutical Services, Inc. - Wihuri Group For more information visit http://www.researchandmarkets.com/research/zk...maceutical
Best's Rating Notification - Cigna HealthCare of Connecticut Inc
Rating Division - AMBest - Thu Feb 13, 12:28PM CST
A.M. Best Company has made the following rating update:
West to Host Fourth Quarter and Full Year 2013 Conference Call
Marketwire - Thu Feb 13, 7:01AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2013 financial results before the market opens on Thursday, February 20, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 800-510-9691 (U.S.) or 617-614-3453 (International). The passcode is 13353040.
Global Prefilled Syringes Market to 2019: Glass Based and Plastic Based Analysis
M2 - Tue Feb 11, 10:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/lz4k3l/prefilled) has announced the addition of the "Global Prefilled Syringes Market to 2019: Glass Based and Plastic Based Analysis" report to their offering. The market for glass prefilled syringes is expected to lose some of its share at the end of the forecast period, which will be eaten up by the market for plastic syringes that will grow at a CAGR of 25% from 2013 to 2019. Prefilled syringes represent one of the fastest growing segments among the injectable drug delivery devices market. This is mainly due to the various advantages associated with the use of prefilled syringes such as ease of administration, reduced risk of cross contamination, less overfill and ease of handling. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Rapid growth in the biologics market, technical advances in the sector and rising preference for self-administration using prefilled syringes, autoinjectors and pen injectors are the major factors driving growth of the global market for prefilled syringes. Currently more than 60% of the drugs under clinical development are biologics and are likely to be approved for parenteral administration. This is because most of the biologics including monoclonal antibodies, vaccines and anticoagulants, are large molecules which need to be administered via parenteral route to achieve the desired therapeutic effect. Likewise, technical advances related with siliconization and needlestick safety and prevention are also expected to drive growth of the market for prefilled syringes. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. Scope of the Report Segment - Glass Prefilled Syringes Market -- By Revenue (USD Million) -- By Volume (Million units) - Plastic Prefilled Syringes Market -- By Revenue (USD Million) -- By Volume (Million units) Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Prefilled Syringes Market Overview Chapter 4 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 Chapter 5 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/lz4k3l/prefilled
2013 Report on the International North America Injectable Drug Delivery Market - Forecasts to 2017
M2 - Thu Jan 23, 5:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/3brffr/north_america) has announced the addition of the "2013 Report on the International North America Injectable Drug Delivery Market - Forecasts to 2017" report to their offering. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices. The major markets covered in this report are United States and Canada. The United States accounted for the largest market of the North American injectable drug delivery technologies market in the year 2012. However, Canada is expected to witness high growth due to growing prevalence of diabetes and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis, increase in approval of injectable formulation and device, favorable reimbursement and rise in injectable cosmetic treatments. This research report categorizes and analyzes the North American injectable drug delivery technologies market under two broad segments - devices and formulations. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Injectable Drug Delivery Devices Technologies Market 5 Injectable Drug Delivery Formulation Technologies Market 6 Injectable Drug Delivery Technologies Market,By Therapeutic Applications 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Antares Pharma - Baxter International - Becton, Dickinson and Company - Eli Lilly And Company - Hospira - Novo Nordisk - Sanofi - Unilife Corporation - West Pharmaceutical Services - Zogenix. For more information visit http://www.researchandmarkets.com/research/3b...th_america
Shares of WST Up 26.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 22, 11:13AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on September 10th, 2013 at $39.24. In approximately 4 months, West Pharmaceutical Services has returned 26.83% as of today's recent price of $49.76.
5 Stocks Going Ex-Dividend Tomorrow: PFLT, GOOD, WST, HRL, LOW
at The Street - Thu Jan 16, 9:00AM CST
PFLT GOOD WST HRL LOW are going ex-dividend tomorrow, Friday, Jan. 17, 2014, 5:00 AM ET
2013 Report on the International and U.S. Pharmaceutical Packaging Market - Trends & Forecast to 2018
M2 - Thu Jan 16, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/f5dcm2/global_and_u_s) has announced the addition of the "2013 Report on the International and U.S. Pharmaceutical Packaging Market - Trends & Forecast to 2018" report to their offering. Packaging of pharmaceuticals ensures protection of the product from various factors such as sunlight, moisture and other environmental factors. This in turn inhibits microbial growth and consequently extends the shelf life of the drug. Pharmaceutical packaging includes bottles, ampoules, blisters, pouches, vials, prefilled syringes and tubes among others. They exhibit various properties such as leakage avoidance, inhibiting the growth of bacteria and barrier against moisture. In addition, increasing global drug counterfeit market and the subsequent development of anti-counterfeiting drug packaging technologies and products is expected to boost the demand for pharmaceutical packaging over the next few years. Furthermore, introduction and implementation of numerous stringent regulations and standards for pharmaceutical packaging by regulatory bodies such as Healthcare Compliance Packaging Council (HCPC), National Quality Forum (NQF) and Food and Drug Administration (FDA) is expected to fuel the growth of the market within the forecast period. Growing demand for pharmaceutical packaging from Asia Pacific on account of increased contract manufacturing, ageing population and growth of pharmaceutical industry are expected to open new opportunities for the market. In addition, shift towards nano-enabled packaging to enhance barrier properties against light, moisture, and mechanical forces is expected to open opportunities for the growth of the market over the next few years. Key Topics Covered: 1 Preface 2 Executive Summary 3 Pharmaceutical Packaging : Industry Analysis 4 Pharmaceutical Packaging Market: Product Segment Analysis 5 Pharmaceutical Packaging Market: Regional Analysis 6 Company Profiles Companies Mentioned: - Amcor - Catalent Pharma Solutions - Gerresheimer - MeadWestvaco - Rexam PLC - Schott AG - West Pharmaceutical Services For more information visit http://www.researchandmarkets.com/research/f5...al_and_u_s
28.4% Return Seen to Date on SmarTrend West Pharmaceutical Services Call (WST)
Comtex SmarTrend(R) - Wed Jan 15, 9:55AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on September 10th, 2013 at $39.24. In approximately 4 months, West Pharmaceutical Services has returned 28.43% as of today's recent price of $50.39.
Upcoming Earnings Conference Calls, FDA Approvals, and Share Price Updates - Research Report on Actavis, ResMed, West Pharmaceutical, Sirona Dental Systems, and Theravance
PR Newswire - Mon Jan 13, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
U.S. Surgical Appliance and Supplies Manufacturing Industry Shipment to Reach US$64 Billion by 2017
M2 - Wed Jan 08, 10:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/g3ns56/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2013 Q4 Edition]" to their offering. The industry's revenue for the year 2012 was reported at $40.9 billion USD, with an estimated gross profit of 45.52%. Import was valued at $12.1 billion USD from 98 countries. The industry also exported $10.6 billion USD worth of merchandise to 190 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2012 was $42.3 billion USD. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through September 2013. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. This 179-page report includes the most recent information on the domestic market, global market and overseas growth opportunities. This report provides the most current data available, such as shipments, inventory and trade data available through September 2013, and sophisticated forecasts up to 2017 accounting for the affects of the recent economic recession. Industry analysts consider this report the most comprehensive and consistently updated guide to the industry. Companies Mentioned: - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/g3ns56/surgical Source: Supplier Relations US, LLC About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Uptrend Call Working As West Pharmaceutical Services Stock Rises 25.4% (WST)
Comtex SmarTrend(R) - Wed Jan 08, 9:29AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on September 10th, 2013 at $39.24. In approximately 4 months, West Pharmaceutical Services has returned 25.37% as of today's recent price of $49.19.
2013 Report on the International Injectable Drug Delivery Market - Includes Forecasts to 2017
M2 - Thu Jan 02, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/5fj7x3/injectable_drug) has announced the addition of the "2013 Report on the International Injectable Drug Delivery Market - Includes Forecasts to 2017" report to their offering. The injectable drug delivery market is technology driven and is marked by the 'Threat of Obsolescence' wherein technologies as well as its adoption by patients changes very rapidly. The industry has seen a shift in paradigm and is now skewed toward self-injection devices that not only cure serious illnesses but also have fewer serious side effects. The market for injectable drug delivery includes devices and formulations. Traditionally, injectable devices were primarily designed for delivery of insulin and human growth hormones. However, due to technological advancements they are currently being used as combination therapies for the delivery of a wide variety of drug classes such as anticholinergic, hematopoietic, dopamine agonists, parathyroid hormones, reproductive hormones, serotonin antagonists, sympathomimetic and immune modulators. Self injection devices including auto injectors and pen injectors are the fastest growing segments in the injectable drug delivery market. In recent years, the uptake and adoption of self-injection devices such as auto and pen injectors has grown substantially. This is due to the benefits it offers over conventional injection devices. Self-injection devices ensure better patient adherence to treatment due to decrease risk of missed injection or drug discontinuation, and reduced healthcare cost as costly hospital visits are curtailed. This has ignited the interest of device manufacturers who are in turn incessantly coming up with new variants of self-injection devices with advanced technological features. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Injectable Drug Delivery Devices Technologies Market 5 Global Injectable Drug Delivery Formulation Technologies Market 6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Alkermes - Antares Pharma - Baxter International - Becton, Dickinson And Company - Bespak Europe - Crossject - Elcam Medical - Eli Lilly And Company - Gerresheimer - Haselmeier - Injex Pharma - Novo Nordisk - Owen Mumford - Sanofi - Schott - Shl Group - Terumo Corporation - Unilife Corporation - Vetter Pharma-Fertigung - West Pharmaceutical Services - Ypsomed Holding - Zogenix For more information visit http://www.researchandmarkets.com/research/5f...table_drug
West to Present at Barclays Conference
Marketwire - Thu Mar 06, 7:02AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the 2014 Barclays Global Healthcare Conference Healthcare Conference in Miami, FL. Management will present an overview of West's business and outlook on Thursday, March 13, 2013 at 9:00 AM Eastern Time.
Concise Analysis of the International Bolus Injectors Market, 2014 - 2024
M2 - Tue Mar 04, 6:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/jpbd3g/bolus_injectors) has announced the addition of the "Concise Analysis of the International Bolus Injectors Market, 2014 - 2024" report to their offering. The injectable drug delivery market holds significant potential for the future. From conventional syringes with vials and painful needles to the modern-day pre-filled syringes, pen-injectors, needle free injectors and auto-injectors, the injectable drug delivery devices market has come a long way. Taking the concept of self-injectors to a new stratum, Bolus Injectors' have surfaced recently. Also known as non-insulin patch pumps, these devices not only offer a range of benefits to the end users but also provide a number of additional benefits to other stakeholders in the industry. One of the main drivers for the perceived growth of bolus injectors is the large number of biologics currently under development. A majority of these molecules are highly viscous and are required to be delivered in volumes of greater than 1 ml. The absence of devices which can safely administer these drugs is currently a big unmet need in the market. However, the early signs are encouraging. Despite the uncertainties related to the device development and approval, many companies are investing time, money and resources to develop novel devices. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Overview And Market Background 4. Target Drugs For Bolus Injectors 5. Product Profiles 6. Market Size And Forecast 7. Swot Analysis 8. Company Profiles 9. Interview Transcripts 10. Conclusion 11. Appendix 1: Tables 12. Appendix 2: List Of Companies Companies Mentioned: - AbbVie - Abbott - BMS - Boehringer Ingelheim - Calando Pharmaceuticals - Calibra Medical - Dekkun - Denderon - Eisai - Elcam Medical - Eli Lilly - Five Prime Therapeutics - Future Injection Technologies - Genentech - Genethon - Isis Pharmaceuticals - J&J - Janssen Biotech - Kyowa Hakko Kirin - Lincoln Medical Limited - MacroGenics - Nuron Biotech - Octapharma - OncoGenex Technologies - Pfizer - PhaseBio Pharmaceuticals - Roche - SteadyMed Therapeutics - Synageva BioPharma - TaiMed Biologics - Takeda Pharmaceuticals - VBL Therapeutics - West Pharmaceutical Services - Xbiotech - Ypsomed - ZZ Biotech For more information visit http://www.researchandmarkets.com/research/jp..._injectors
Insider Trading Alert - KMB, IBKR And WST Traded By Insiders
at The Street - Thu Feb 27, 9:30AM CST
Stocks with insider trader activity include KMB, IBKR and WST
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
West Pharm sales fall short
at Investor's Business Daily - Thu Feb 20, 6:14PM CST
The maker of packaging and delivery devices for drugs and related consumer products said Q4 EPS climbed 22.6% to 38 cents, in line with estimates. Revenue rose 7.8% to $346.6 mil, below projections for $348.7 mil. West Pharmaceutical (WST) forecast...
West Appoints Director and Announces Second Quarter 2014 Dividend
Marketwire - Thu Feb 20, 7:22AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors increased the size of the Board to eleven and appointed Myla Lai-Goldman, M.D., for a term that will expire at the 2014 Annual Meeting of Shareholders, when she will stand for election.
West Announces Fourth Quarter 2013 Results
Marketwire - Thu Feb 20, 6:01AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth quarter and full year 2013 and provided annual financial guidance for 2014.
Global Pharmaceutical Packaging Market Report 2014-2018: Plastic bottles, Blister packs, Caps & Closures, Ampoules, Vials and Others
M2 - Fri Feb 14, 9:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/zkfvpk/pharmaceutical) has announced the addition of the "Pharmaceutical Packaging Market by Packaging Type. Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018" report to their offering. The global pharmaceutical packaging market is expected to grow at a CAGR of 6.7% from 2013 to 2018 to reach a value of $78.79 billion. The pharmaceutical packaging report analyzes pharmaceutical packaging market by type of packaging and drug delivery technologies; globally & regionally. The report familiarizes the industry players with the market trends, opportunities, drivers, and challenges. This report identifies the factors driving or inhibiting the growth of each segment to support its analysis of market trends and forecasts. In addition to the market size, data trends, and forecasts; the report also highlights the key market opportunities for the stakeholders and draws a competitive landscape in which the key market developments of the top companies in the market are profiled. The packaging market by drug delivery type is growing at a CAGR of 9.1% and constitutes a significant part of the overall pharmaceutical packaging market. The market is expected to be pushed by off-patenting of drugs, expanding generics market, and rapidly growing drug delivery market. Due to increasing generic and contract manufacturing activities in Asia-Pacific, especially in India and China, the emerging geographies are expected to register maximum growth. Advances in biotechnology often lead to the introduction of new therapies that must be injected; the pharmaceutical packaging market is expected to witness fastest growth from pre-fillable syringes and parenteral vials. Availability of raw materials and price volatility coupled with changing health regulations are the major deterrents that are curbing the growth of this market. The fastest growth in the pharma packaging market is expected to come from pre-fillable syringes, labels and accessories, blister packs, temperature controlled medicines packaging, and few niche products, which will continue to expand in the coming years. Mergers and acquisitions in the recent past have indicated that the industry is on its way to consolidation globally and global packaging suppliers are strengthening their presence in emerging markets. All these factors, along with the growing pharma industry, will continue to drive the demand for packaging. However, the packaging industry will have to overcome challenges, such as the availability and price volatility of raw materials and changing health regulations, in order to meet the increasing demand from the growing pharma industry. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Premium Insight 5 Market Dynamics 6 Pharmaceutical Packaging Market, By Packaging Type 7 Pharmaceutical Packaging Market, By Packaging Material 8 Pharmaceutical Packaging Market, By Drug Delivery Type 9 Pharmaceutical Packaging Market, By Geography 10 Packaging Market For Veterinary Vaccines 11 Competitive Landscape 12 Company Profiles - Amcor Ltd. - Aptargroup, Inc. - Becton, Dickinson & Company - Capsugel Inc. - Catalent Pharma Solutions Inc. - Ccl Industries Inc. - Clondalkin Group Holdings B.V. - Datwyler Holding Inc. - Gerresheimer Ag - Global Closure Systems Ltd - Intrapac Group - Klockner Pentaplast Group - Meadwestvaco Corporation - Nypro Inc. - Rexam Plc - Rpc Group Plc - Schott Ag - Steripack Limited - Vitro, S.A.B. De C.V. - West Pharmaceutical Services, Inc. - Wihuri Group For more information visit http://www.researchandmarkets.com/research/zk...maceutical
Best's Rating Notification - Cigna HealthCare of Connecticut Inc
Rating Division - AMBest - Thu Feb 13, 12:28PM CST
A.M. Best Company has made the following rating update:
West to Host Fourth Quarter and Full Year 2013 Conference Call
Marketwire - Thu Feb 13, 7:01AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2013 financial results before the market opens on Thursday, February 20, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 800-510-9691 (U.S.) or 617-614-3453 (International). The passcode is 13353040.
Global Prefilled Syringes Market to 2019: Glass Based and Plastic Based Analysis
M2 - Tue Feb 11, 10:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/lz4k3l/prefilled) has announced the addition of the "Global Prefilled Syringes Market to 2019: Glass Based and Plastic Based Analysis" report to their offering. The market for glass prefilled syringes is expected to lose some of its share at the end of the forecast period, which will be eaten up by the market for plastic syringes that will grow at a CAGR of 25% from 2013 to 2019. Prefilled syringes represent one of the fastest growing segments among the injectable drug delivery devices market. This is mainly due to the various advantages associated with the use of prefilled syringes such as ease of administration, reduced risk of cross contamination, less overfill and ease of handling. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Rapid growth in the biologics market, technical advances in the sector and rising preference for self-administration using prefilled syringes, autoinjectors and pen injectors are the major factors driving growth of the global market for prefilled syringes. Currently more than 60% of the drugs under clinical development are biologics and are likely to be approved for parenteral administration. This is because most of the biologics including monoclonal antibodies, vaccines and anticoagulants, are large molecules which need to be administered via parenteral route to achieve the desired therapeutic effect. Likewise, technical advances related with siliconization and needlestick safety and prevention are also expected to drive growth of the market for prefilled syringes. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. Scope of the Report Segment - Glass Prefilled Syringes Market -- By Revenue (USD Million) -- By Volume (Million units) - Plastic Prefilled Syringes Market -- By Revenue (USD Million) -- By Volume (Million units) Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Prefilled Syringes Market Overview Chapter 4 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 Chapter 5 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/lz4k3l/prefilled
2013 Report on the International North America Injectable Drug Delivery Market - Forecasts to 2017
M2 - Thu Jan 23, 5:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/3brffr/north_america) has announced the addition of the "2013 Report on the International North America Injectable Drug Delivery Market - Forecasts to 2017" report to their offering. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices. The major markets covered in this report are United States and Canada. The United States accounted for the largest market of the North American injectable drug delivery technologies market in the year 2012. However, Canada is expected to witness high growth due to growing prevalence of diabetes and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis, increase in approval of injectable formulation and device, favorable reimbursement and rise in injectable cosmetic treatments. This research report categorizes and analyzes the North American injectable drug delivery technologies market under two broad segments - devices and formulations. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Injectable Drug Delivery Devices Technologies Market 5 Injectable Drug Delivery Formulation Technologies Market 6 Injectable Drug Delivery Technologies Market,By Therapeutic Applications 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Antares Pharma - Baxter International - Becton, Dickinson and Company - Eli Lilly And Company - Hospira - Novo Nordisk - Sanofi - Unilife Corporation - West Pharmaceutical Services - Zogenix. For more information visit http://www.researchandmarkets.com/research/3b...th_america
Shares of WST Up 26.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 22, 11:13AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on September 10th, 2013 at $39.24. In approximately 4 months, West Pharmaceutical Services has returned 26.83% as of today's recent price of $49.76.
5 Stocks Going Ex-Dividend Tomorrow: PFLT, GOOD, WST, HRL, LOW
at The Street - Thu Jan 16, 9:00AM CST
PFLT GOOD WST HRL LOW are going ex-dividend tomorrow, Friday, Jan. 17, 2014, 5:00 AM ET
2013 Report on the International and U.S. Pharmaceutical Packaging Market - Trends & Forecast to 2018
M2 - Thu Jan 16, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/f5dcm2/global_and_u_s) has announced the addition of the "2013 Report on the International and U.S. Pharmaceutical Packaging Market - Trends & Forecast to 2018" report to their offering. Packaging of pharmaceuticals ensures protection of the product from various factors such as sunlight, moisture and other environmental factors. This in turn inhibits microbial growth and consequently extends the shelf life of the drug. Pharmaceutical packaging includes bottles, ampoules, blisters, pouches, vials, prefilled syringes and tubes among others. They exhibit various properties such as leakage avoidance, inhibiting the growth of bacteria and barrier against moisture. In addition, increasing global drug counterfeit market and the subsequent development of anti-counterfeiting drug packaging technologies and products is expected to boost the demand for pharmaceutical packaging over the next few years. Furthermore, introduction and implementation of numerous stringent regulations and standards for pharmaceutical packaging by regulatory bodies such as Healthcare Compliance Packaging Council (HCPC), National Quality Forum (NQF) and Food and Drug Administration (FDA) is expected to fuel the growth of the market within the forecast period. Growing demand for pharmaceutical packaging from Asia Pacific on account of increased contract manufacturing, ageing population and growth of pharmaceutical industry are expected to open new opportunities for the market. In addition, shift towards nano-enabled packaging to enhance barrier properties against light, moisture, and mechanical forces is expected to open opportunities for the growth of the market over the next few years. Key Topics Covered: 1 Preface 2 Executive Summary 3 Pharmaceutical Packaging : Industry Analysis 4 Pharmaceutical Packaging Market: Product Segment Analysis 5 Pharmaceutical Packaging Market: Regional Analysis 6 Company Profiles Companies Mentioned: - Amcor - Catalent Pharma Solutions - Gerresheimer - MeadWestvaco - Rexam PLC - Schott AG - West Pharmaceutical Services For more information visit http://www.researchandmarkets.com/research/f5...al_and_u_s
28.4% Return Seen to Date on SmarTrend West Pharmaceutical Services Call (WST)
Comtex SmarTrend(R) - Wed Jan 15, 9:55AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on September 10th, 2013 at $39.24. In approximately 4 months, West Pharmaceutical Services has returned 28.43% as of today's recent price of $50.39.
Upcoming Earnings Conference Calls, FDA Approvals, and Share Price Updates - Research Report on Actavis, ResMed, West Pharmaceutical, Sirona Dental Systems, and Theravance
PR Newswire - Mon Jan 13, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
U.S. Surgical Appliance and Supplies Manufacturing Industry Shipment to Reach US$64 Billion by 2017
M2 - Wed Jan 08, 10:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/g3ns56/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2013 Q4 Edition]" to their offering. The industry's revenue for the year 2012 was reported at $40.9 billion USD, with an estimated gross profit of 45.52%. Import was valued at $12.1 billion USD from 98 countries. The industry also exported $10.6 billion USD worth of merchandise to 190 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2012 was $42.3 billion USD. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through September 2013. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. This 179-page report includes the most recent information on the domestic market, global market and overseas growth opportunities. This report provides the most current data available, such as shipments, inventory and trade data available through September 2013, and sophisticated forecasts up to 2017 accounting for the affects of the recent economic recession. Industry analysts consider this report the most comprehensive and consistently updated guide to the industry. Companies Mentioned: - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/g3ns56/surgical Source: Supplier Relations US, LLC About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Uptrend Call Working As West Pharmaceutical Services Stock Rises 25.4% (WST)
Comtex SmarTrend(R) - Wed Jan 08, 9:29AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on September 10th, 2013 at $39.24. In approximately 4 months, West Pharmaceutical Services has returned 25.37% as of today's recent price of $49.19.
2013 Report on the International Injectable Drug Delivery Market - Includes Forecasts to 2017
M2 - Thu Jan 02, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/5fj7x3/injectable_drug) has announced the addition of the "2013 Report on the International Injectable Drug Delivery Market - Includes Forecasts to 2017" report to their offering. The injectable drug delivery market is technology driven and is marked by the 'Threat of Obsolescence' wherein technologies as well as its adoption by patients changes very rapidly. The industry has seen a shift in paradigm and is now skewed toward self-injection devices that not only cure serious illnesses but also have fewer serious side effects. The market for injectable drug delivery includes devices and formulations. Traditionally, injectable devices were primarily designed for delivery of insulin and human growth hormones. However, due to technological advancements they are currently being used as combination therapies for the delivery of a wide variety of drug classes such as anticholinergic, hematopoietic, dopamine agonists, parathyroid hormones, reproductive hormones, serotonin antagonists, sympathomimetic and immune modulators. Self injection devices including auto injectors and pen injectors are the fastest growing segments in the injectable drug delivery market. In recent years, the uptake and adoption of self-injection devices such as auto and pen injectors has grown substantially. This is due to the benefits it offers over conventional injection devices. Self-injection devices ensure better patient adherence to treatment due to decrease risk of missed injection or drug discontinuation, and reduced healthcare cost as costly hospital visits are curtailed. This has ignited the interest of device manufacturers who are in turn incessantly coming up with new variants of self-injection devices with advanced technological features. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Injectable Drug Delivery Devices Technologies Market 5 Global Injectable Drug Delivery Formulation Technologies Market 6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Alkermes - Antares Pharma - Baxter International - Becton, Dickinson And Company - Bespak Europe - Crossject - Elcam Medical - Eli Lilly And Company - Gerresheimer - Haselmeier - Injex Pharma - Novo Nordisk - Owen Mumford - Sanofi - Schott - Shl Group - Terumo Corporation - Unilife Corporation - Vetter Pharma-Fertigung - West Pharmaceutical Services - Ypsomed Holding - Zogenix For more information visit http://www.researchandmarkets.com/research/5f...table_drug
